2026 Conference Program

 

 

April 24, 2026

8:15 – 8:30 | Introduction
8:30 – 8:50 | Dr. Keillor Steeves – “Update on the Management of T2D and MASLD in NB”
8:50 – 9:00 | Q & A
At the end of this presentation, participants will be able to:

• Describe the impacts of MASLD on patients in NB living with diabetes.
• Explain non-pharmacologic options for the prevention and management of MASLD in T2D
• Compare pharmacologic options to reduce steatohepatitis and progression of fibrosis of MASLD in T2D

CanMEDS Roles: Medical Expert, Health Advocate, Leader, Collaborator

9:00 – 9:20 | Dr. Stuart McAdam – “Hypertension Canada Guideline Update”
9:20 – 9:30 | Q & A

At the end of this presentation, participants will be able to:

• Review the diagnosis of hypertension.
• Identify the new treatment targets for hypertension.
• Discuss first line management of hypertension.

CanMEDS Roles: Medical Expert, Leader, Scholar

9:30 – 9:50 | Dr. Mike Pelkey – “Hyperaldosteronism – Interpretation of the screening results, and when to explore further”
9:50 – 10:00 | Q & A

At the end of this presentation, participants will be able to:

• Review Aldosterone physiology and why hyperaldosteronism should be screened.
• Analyze the aldosterone and renin ratio and determine when to consider confirmatory tests.
• Interpret the results in the context of medications that may alter the system.

CanMEDS Roles: Medical Expert, Scholar

10:00 – 10:15 | Health Break
10:15 – 10:35 | Dr. Eslam Abdellah – ““From ER to Long-Term Prevention: Practical Stroke Updates for 2026”
10:35 – 10:45 | Q & A

At the end of this presentation, participants will be able to:

• Identify which acute ischemic stroke patients benefit from current reperfusion strategies and appropriate blood pressure targets.
• Apply evidence-based antithrombotic strategies after TIA or Ischemic Stroke.
• Implement practical secondary prevention strategies that reduce recurrent stroke risk.

CanMEDS Roles: Medical Expert, Health Advocate

10:45 – 11:05 | Dr. Heather Chambers – “Approach to the Undifferentiated Patient”
11:05 – 11:15 | Q & A

At the end of this presentation, participants will be able to:

• Consider the elements of a cognitive framework to guide assessment of Undifferentiated Patient.
• Examine the role of cognitive patterns and cognitive bias in such a framework.
• Assess the usefulness of such an approach in one’s own clinical practice.

CanMEDS Roles: Medical Expert, Professional, Scholar, Leader

11:15 – 11:35 | Dr. Jacqueline Mouris – “Management of Urticaria, Angioedema, and Anaphylaxis”
11:35 – 11:45 | Q & A

At the end of this presentation, participants will be able to:

• Define Chronic Spontaneous Urticaria and describe its key clinical features.
• Identify the diagnostic criteria and recommended evaluation approach for CSU, including differentiation from other types of urticaria and related conditions.
• Discuss current evidence-based management strategies for CSU, including stepwise pharmacologic treatment and emerging therapies.
• Evaluate the impact of CSU on patient’s quality of life and outline strategies for long- term monitoring, patient education, and multidisciplinary care.

CanMEDS Roles: Medical Expert, Communicator, Health Advocate, Collaborator

11:45 – 12:55 | Lunch Break

Afternoon

12:55 – 1:00 | Dr. Peter Lightfoot lecture – Introduction
1:00 – 1:45 | Dr. Peter Lightfoot lecture – Dr. Mohammed Mamdani – “Applied Artificial Intelligence in Healthcare”
1:45 – 2:00 | Q & A

At the end of this presentation, participants will be able to:

• Review the “current state” of AI in healthcare.
• Identify key opportunities and challenges of applying AI to healthcare: separating “hype” from reality.
• Discuss the future direction of AI in healthcare.

CanMEDS Roles: Leader, Professional, Scholar, Collaborator, Medical Expert

2:00 – 2:20 | Dr. N. Gionet Landry – “Ehlers-Danlos : diagnosis and follow-up”
2:20 – 2:30 | Q & A

At the end of this presentation, participants will be able to:

• Identify key clinical features of Ehlers-Danlos syndromes using practical beside tools (e.g., Beighton score) and recognize red flags requiring specialty referral.
• Apply a simplified diagnostic approach to differentiate EDS from common mimickers.
• Implement an evidence-informed follow-up plan, including symptom-based management and appropriate long-term monitoring.

CanMEDS Roles: Medical Expert, Collaborator, Health Advocate

2:30 – 2:45 | Health Break
2:45 – 3:05 | Dr. Abeer Al-Baadani – “Update on Lyme disease”
3:05 – 3:15 | Q & A

At the end of this presentation, participants will be able to:

• Describe the epidemiology and transmission of Lyme disease.
• Recognize the clinical manifestations of Lyme disease.
• Apply current diagnostic strategies based on the best available evidence.
• Select evidence-based treatment regiments.
• Identify complications and post-treatment syndromes.

CanMEDS Roles: Medical Expert, Health Advocate

3:15 – 3:35 | Dr. Mike MacGillivary – “When Internal Malignancy breaks the 4 th wall: Skin manifestations of non-cutaneous cancers”
3:15 – 3:45 | Q & A

At the end of this presentation, participants will be able to:

• Recall five paraneoplastic dermatosis and their potential underpinnings.
• Distinguish when common skin diagnosis may indicate an internal malignancy.
• Select which skin manifestations of a paraneoplastic nature necessitates emergent dermatological referral.

CanMEDS Roles: Medical Expert, Collaborator

3:45 – 4:00 | Closing Remarks